D016899Chemicals & DrugsD12.644.276.374.440.890.275D12.776.467.374.440.890.275D23.529.374.440.890.275381250.923788Interferon-betaprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonRadiation and Cellular Oncology31582399Feng X, Wang Z, Howlett-Prieto Q, Einhorn N, Causevic S, Reder ATNeurology(R) neuroimmunology & neuroinflammationVitamin D enhances responses to interferon-ß in MS. Neurol Neuroimmunol Neuroinflamm. 2019 11; 6(6):e622.Neurol Neuroimmunol Neuroinflamm2019-10-03T00:00:002019Vitamin D enhances responses to interferon-ß in MS.31648992Feng X, Bao R, Li L, Deisenhammer F, Arnason BGW, Reder ATEBioMedicineInterferon-ß corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection. EBioMedicine. 2019 Nov; 49:269-283.EBioMedicine2019-10-21T00:00:002019Interferon-ß corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection.6.579140.0071184838research area of0.7353320.0286839114subject area forNeurologyPathologyUniversity of ChicagoAnthony T.RederAnthony T. Reder41.78927490000000-87.601250000000001239Reder, Anthony T.ProfessorBarry G.ArnasonBarry G. Arnason41.78927490000000-87.601250000000001802Arnason, Barry G.ProfessorRalph R.WeichselbaumxXB+DqgWEf/5hHlsaUXv9Gq0+s+oRalph R. Weichselbaum41.78927490000000-87.601250000000002521Weichselbaum, Ralph R.ProfessorThomas F.GajewskiThomas F. Gajewski41.78927490000000-87.60125000000000355Gajewski, Thomas F.ProfessorXuanFengXuan Feng41.78927490000000-87.60125000000000892Feng, XuanResearch Associate (Assistant Professor)true1ProfessorProfessortrue1Research Associate (Assistant Professor)Research Associate (Assistant Professor)true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor25330068Yu L, Croze E, Yamaguchi KD, Tran T, Reder AT, Litvak V, Volkert MRJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine ResearchInduction of a unique isoform of the NCOA7 oxidation resistance gene by interferon ß-1b. J Interferon Cytokine Res. 2015 Mar; 35(3):186-99.J Interferon Cytokine Res2014-10-20T00:00:002014Induction of a unique isoform of the NCOA7 oxidation resistance gene by interferon ß-1b.25888642Otero DC, Fares-Frederickson NJ, Xiao M, Baker DP, David MJournal of immunology (Baltimore, Md. : 1950)IFN-ß Selectively Inhibits IL-2 Production through CREM-Mediated Chromatin Remodeling. J Immunol. 2015 Jun 01; 194(11):5120-8.J Immunol2015-04-17T00:00:002015IFN-ß Selectively Inhibits IL-2 Production through CREM-Mediated Chromatin Remodeling.27034163Ranoa DR, Parekh AD, Pitroda SP, Huang X, Darga T, Wong AC, Huang L, Andrade J, Staley JP, Satoh T, Akira S, Weichselbaum RR, Khodarev NNOncotargetCancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs. Oncotarget. 2016 May 03; 7(18):26496-515.Oncotarget2016-05-03T00:00:002016Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs.